1. Home
  2. Directory
  3. Indiana
  4. South Bend
  5. Radiology
  6. NPI Profile
  7. Prescriptions 1790770964

DAVID ALAN HORNBACK MD
Prescription History 1790770964
Radiology - Radiation Oncology in South Bend, IN

NPI Status: Active since September 14, 2005

Contact Information

621 MEMORIAL DR STE 100
SOUTH BEND, IN
ZIP 46601
Phone: (574) 647-1100

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DAVID ALAN HORNBACK MD, an active Radiation Oncology specialist practicing in South Bend, IN. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 166 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamsulosin Hcl, which accounts for 75 claims alone.

Medication Index

C
G
O
P
T
No matching medications currently found on file.

Cephalexin

Generic Formulation: CephalexinSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 18
30-Day Fills 18.0
Days Supply 104
IN State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills36.4
Peer Average Days Supply393
Conservative Utilization

This provider writes prescriptions for this formulation 45.5% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $54.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.02

State Avg Cost Per Claim

$8.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Gabapentin

Generic Formulation: GabapentinSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 32
30-Day Fills 46.3
Days Supply 1,319
IN State Average Benchmarks
Peer Average Claims107.0
Peer Average 30-Day Fills170.0
Peer Average Days Supply4,888
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 70.1% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $822.23 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.69

State Avg Cost Per Claim

$20.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Oxybutynin Chloride

Generic Formulation: Oxybutynin ChlorideSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 28
30-Day Fills 34.0
Days Supply 945
IN State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills52.2
Peer Average Days Supply1,493
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $333.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.90

State Avg Cost Per Claim

$25.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (such as spina bifida).

Pilocarpine Hcl

Generic Formulation: Pilocarpine HclSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 13
30-Day Fills 22.0
Days Supply 660
IN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills38.0
Peer Average Days Supply1,099
Conservative Utilization

This provider writes prescriptions for this formulation 40.9% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,255.86 across this reporting matrix range.

Provider Avg Cost Per Claim

$96.60

State Avg Cost Per Claim

$91.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.

Therapeutic Applications

This medication is used to treat symptoms of dry mouth due to a certain immune disease (Sjogren's syndrome) or from saliva gland damage due to radiation treatments of the head/neck for cancer. Pilocarpine belongs to a class of drugs known as cholinergic agonists. It works by stimulating certain nerves to increase the amount of saliva you produce, making it easier and more comfortable to speak and swallow.

Tamsulosin Hcl

Generic Formulation: Tamsulosin HclSpecialty: Radiation Oncology
Provider Metrics Summary
Total Claims 75
30-Day Fills 177.3
Days Supply 5,318
IN State Average Benchmarks
Peer Average Claims94.0
Peer Average 30-Day Fills211.0
Peer Average Days Supply6,167
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,763.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.51

State Avg Cost Per Claim

$20.52

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DAVID ALAN HORNBACK MD provides transparency into local medical care patterns within South Bend, IN.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Radiation Oncology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.